Good News for Statin Users
A long-term study, including 133,255 participants, has found that statin use is unlikely to increase or decrease overall cancer risk. Researchers, presenting this week at the Cancer Prevention Research Conference, studied the association between statin use (and other cholesterol-lowering drugs) and the occurrence of the 10 most common cancers, as well as overall cancer risk. Findings revealed that using cholesterol-lowering drugs for five years or more wasn't tied with overall cancer incidence. In addition, using the drugs wasn't associated with incidence of bladder, breast, colorectal, lung, pancreatic, prostate, or renal cell cancer. The drugs were associated with a lower risk of endometrial cancer, melanoma and non-Hodgkin lymphoma.
150 Minutes a Week Reduces Risk
Exercising for 150 minutes a week or more might help you reduce your risk of getting endometrial cancer, claim researchers presenting this week at the Cancer Prevention Research Conference. The research, conducted at Yale School of Public Health, included 668 women with endometrial cancer and 665 age-matched control women without cancer. Researchers found that women who exercised 150 minutes a week or more had a 34 percent reduced risk of endometrial cancer when compared to inactive women. The link between exercise and endometrial cancer risk reduction was more pronounced among active women who had a body mass index (BMI) less than 25. Yet, even overweight, but still active women had a lower risk compared to the inactive women.